JavaScript is disabled for your browser. Some features of this site may not work without it.
Effect of Time in Therapeutic Range on Cost and Clinical Outcomes of Atrial Fibrilation Patients : A Cost-Consequences Analysis of Rivaroxaban Vs Warfarin For Turkey